Literature DB >> 18833422

Cataract occurrence in patients treated with antipsychotic drugs.

Valéria Barreto Novais e Souza1, Francisco José Rodrigues de Moura Filho, Fábio Gomes de Matos e Souza, Camila Farias Rocha, Fernando Antônio Mendes Lopes Furtado, Tiago Bessa Almeida Gonçalves, Karla Feitosa Ximenes Vasconcelos.   

Abstract

OBJECTIVE: Typical antipsychotic drugs, mainly phenothiazines, have been associated with cataract formation for over forty years. Recently, there has been a concern about atypical antipsychotic drugs' potential for inducing this lenticular pathology. Accordingly, we sought to determine the cataract rate and other ocular side effects in patients on long-term therapy with antipsychotic drugs.
METHOD: Eighty outpatients with DSM-IV diagnosis of schizophrenia from two settings who met pre determined inclusion criteria were submitted to an ophthalmological evaluation for ocular abnormalities with emphasis in the lens and cornea. They were divided into two groups: group 1 (n = 52) comprised patients who had been predominantly on typical antipsychotics for at least two years and group 2 (n = 28) patients who had been predominantly on atypical antipsychotics for at least two years.
RESULTS: Cataract was found in 26 patients (33%) with predominance of anterior capsular cataract. The cataract rate among patients from group 1 (40%) was higher than among those from group 2 (18%). Visual acuity was reduced in 21 patients (26%). No changes were observed neither in the cornea nor in the retina.
CONCLUSIONS: Patients using antipsychotic drugs should be submitted to a periodic ophthalmological evaluation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18833422     DOI: 10.1590/s1516-44462008000300008

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN: 1516-4446            Impact factor:   2.697


  7 in total

1.  GluA2 AMPA glutamate receptor subunit exhibits codon 607 Q/R RNA editing in the lens.

Authors:  Mohammed Farooq; Rajesh H Kaswala; Norman J Kleiman; Chinnaswamy Kasinathan; Peter H Frederikse
Journal:  Biochem Biophys Res Commun       Date:  2012-01-10       Impact factor: 3.575

2.  Schizophrenia in Translation: Why the Eye?

Authors:  Steven M Silverstein; Joy J Choi; Kyle M Green; Kristen E Bowles-Johnson; Rajeev S Ramchandran
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

3.  Bilateral cataracts in a young patient with bipolar disorder on treatment with risperidone.

Authors:  Ekta Patel; Juan A Gallego
Journal:  Aust N Z J Psychiatry       Date:  2016-06-23       Impact factor: 5.744

4.  Clozapine-induced cataract in a young female.

Authors:  Md Shahid Alam; K V Praveen Kumar
Journal:  J Pharmacol Pharmacother       Date:  2016 Oct-Dec

5.  In vitro melanogenesis inhibition by fluphenazine and prochlorperazine in normal human melanocytes lightly pigmented.

Authors:  Michał Otręba; Artur Beberok; Dorota Wrześniok; Ewa Buszman
Journal:  Daru       Date:  2018-07-24       Impact factor: 3.117

6.  Olanzapine-induced Cataract in a Teenage Girl.

Authors:  Chang Zhen Lim; Khairy Shamel Sonny Teo; Evelyn Tai
Journal:  Cureus       Date:  2018-04-30

7.  Schizophrenia and the eye.

Authors:  Steven M Silverstein; Richard Rosen
Journal:  Schizophr Res Cogn       Date:  2015-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.